transbiotec introduces sobr
TRANSCRIPT
TRANSBIOTEC
SOBR
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 1
TRANSBIOTEC
Forward Looking Statement• This presentation contains “forward-looking statements” within the meaning of the “safe harbor” provisions of
the Private Securities Litigation Reform Act of 1995. All of the statements in this presentation, whether written or oral, that refer to expected or anticipated future actions and results of TransBiotec, Inc. (TransBiotec) are forward-looking statements. These forward-looking statements reflect the beliefs and expectations of the management of TransBiotec as of the date of this presentation. TransBiotec cannot give any assurance that such forward-looking statements will prove to be correct. The reader is cautioned not to place undue reliance on these forward-looking statements.
• The information provided in this presentation does not identify or include any risk or exposures, of TransBiotec that would materially adversely affect the performance or risk of the company. For a description of the risks and uncertainties related to the business of TransBiotec, see our Annual Report on Form 10-K for the year ended April 15, 2015 filed with the Securities and Exchange Commission on April 15, 2015 and our subsequent periodic reports filed with the Securities and Exchange Commission.
• All information contained in this presentation is provided as of the date of the presentation and is subject to change without notice. Neither TransBiotec, nor any other person undertakes any obligation to update or revise publicly any of the forward-looking statements set out herein, whether as a result of new information, future events or otherwise, except as required by law. This presentation does not convey an offer of any type and is not intended to be, and should not be construed as, an offer to sell, or the solicitation of an offer to buy, any securities of TransBiotec.
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 2
TRANSBIOTEC
Company Overview• TransBioTec, Inc. is a publicly traded, biotech company, developing
alcohol detection devices designed to reduce alcohol related deaths and injuries.
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 3
OTCQB NMUS
Price (3/9/16) $0.006
Market Cap (3/9/16) $362 K
Shares Outstanding 67.7 M common & 2.0M PS,
% Ownership by Directors & Employees 11.2% shares
Warrants Outstanding 3.5 M (Avg. Strike @ $1.00)
Founded 2004
Base of Operations Santa Ana, CA
TRANSBIOTEC
• To be the global leader in developing technology to prevent alcohol related accidents
• MISSION Make safety a paramount goal in the creation of our
product Product Quality Work responsibly Lead by example Deliver on our promises and aim to exceed expectations
VISION
05/03/2023 4TRANSBIOTEC PRIVATE / PROPRIETARY
TRANSBIOTEC
GLOBAL MARKET•A $7 billion International Market for devices to detect and prevent alcohol related accidents.
•$1.5 billion US market
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 5
TRANSBIOTEC
The Problem: Driving Under the Influence (DUI)• One person is killed every half-hour due to DUI, a crime
of driving a motor vehicle while impaired by alcohol
• Each year approximately 16,000 are killed in alcohol related crashes
• Alcohol is a factor in almost half of all traffic fatalities
• Every other minute a person is seriously injured in an alcohol related crash
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 6
TRANSBIOTEC
“Ignition Interlocks Reduce Alcohol-Impaired Driving”
• Recent Press release by CDC
• February 22, 2011CDC Injury Center Media Relations
• Ignition Interlocks Reduce Alcohol-Impaired Driving
• Ignition interlocks help prevent drivers who were previously arrested for driving while intoxicated (DWI) from being re-arrested, according to researchers at the Centers for Disease Control and Prevention.
• CDC recommends:
• More widespread use of interlocks.
• Ignition interlocks for everyone convicted of DWI, even for first convictions.
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 7
TRANSBIOTEC
“Sales of Ignition Interlock Devices”• "Sales of Ignition Interlock Devices... may jump to as much as $1.1 billion a
year according to data compiled by Bloomberg." - Bloomberg News
• The Alcohol Ignition Interlock Industry is experiencing tremendous growth as more and more states continue to pass laws requiring Ignition Interlock Devices for DUI/DWI offenders.
• According to the Centers for Disease Control and Prevention, requiring or highly incentivizing interlocks for all convicted drunken drivers reduces drunken driving recidivism by 67 percent.
• Mothers Against Drunk Driving (MADD) Continues to Push for Tougher DUI Laws. In 2006, there were only 100,000 interlocks installed in the United States. As of July 2013, there were nearly 305,000 interlocks in use.
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 8
TRANSBIOTEC
Serious Consequences (USA)• Deaths and Injuries from drunk driving occur year round and
increase during holidays.
• During December from 2007 to 2011, there were 4,169 people killed in crashes that involved drivers with a Blood Alcohol Concentrations (BAC) of .08 grams per deciliter or higher.
• According to the National Highway Traffic Safety Administration, 32,367 people were killed in motor vehicle traffic crashes in 2011, and 31 percent (9,878) of those fatalities occurred in drunk-driving-related crashes.
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 9
TRANSBIOTEC
Alcohol Related Vehicle Fatalities
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 10
Average 40.7% of Total Vehicle Fatalities are Alcohol Related
TRANSBIOTEC
Vehicle Fatalities Involving Alcohol By Person Type
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 11
Primary Fatalities are Pedestrians and Occupants
TRANSBIOTEC
DUI Statistics – A Pictorial View
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 12
TRANSBIOTEC
Road Traffic Accidents Worldwide
50% Estimated Are Drunk Driving Fatalities
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 13
TRANSBIOTEC
Existing Market• Employs breath analyzer device that employs outdated technology
Designed for estimating BAC from a breath sample.
• Breath Analyzer technology is “Invasive” by blowing into a tube for a test reading.
Breath Analyzer Employs Outdated Invasive Technology
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 14
TRANSBIOTEC
THE SOLUTION:
SOBR 05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 15
TRANSBIOTEC
SOBR• TRANSBIOTEC has developed the SOBR device to monitor and test a
person’s blood alcohol concentration (BAC) level.
• SOBR is the first entirely non-intrusive and non-invasive product in the market specific to ethanol alcohol. It tests a person’s ethanol alcohol level to ensure the person is not driving under the influence.
• The SOBR product line includes an Ignition Interlock Device (IID) and a Portable Handheld Device.
The IID, is an in vehicle device, that prevents starting a vehicle when a driver’s alcohol level is above the preset limits.
The Portable Handheld device tests a person’s alcohol level on the spot.
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 16
TRANSBIOTEC
SOBR Continues …• Proprietary and Patented product,3 US Patents and a patent pending.
• Non-Invasive technology for BAC analysis
• Uses a Single-Touch technology
• IS NOT a “breath analyzer”
• Low cost
• A global product with LCD display and LED indicators
• Minimize language translation due to numerical LCD display and LED indicators
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 17
TRANSBIOTEC
SOBR Feature Benefits• Ethanol alcohol is distinguished from other elements
• No distraction to driver (IID only)
• NON-INVASIVE – Finger Touch Sensitive
• Easy retrofit installation (IID only)
• Unobtrusive in the vehicle (IID only)
• No circumvention
• Patented product
• Easy to calibrate
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 18
TRANSBIOTEC
The IID Product• Prevents starting a vehicle when the ethanol alcohol level detected
correlates with BAC above preset limits.
• IID can be installed in automobiles, commercial trucks and industrial equipment.
• Independent studies have shown the IID device is a reliable solution.
• How it works: To start the vehicle, a driver or operator, touches the IID’s sensor to provide a
sample for testing. If the drivers alcohol level is above the preset value, the IID will interrupt the
signal from the ignition switch to the starter, and the vehicle will not start. If there is no sample test or a valid test sample, the vehicle will not start.
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 19
TRANSBIOTEC
SOBR IID
Pre-Production / Demonstration Unit05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 20
Innovation Technology: Single Touch & Non-Invasive
TRANSBIOTEC
IID SpecificationsSOBR
BAC Range 0.01 to 0.13%Warm up Time None when connected to a constant power sourceResponse time within 6 seconds
Recycle time 20 seconds
Input Method Index Finger Touch on Sensor (Non-Invasive)Sensor Tin Oxide Solid State Sensor
Power Supply Vehicle Power Source: 9V DC; 120V ACDimension(mm) 58 x 64 x 95
Remarks USA Design and Patented
Recalibration 12 monthsOperating Temperature -10 deg Cent to +50 deg C
Accuracy ±
Display LED: Green indicates BAC <0.04; Red indicates BAC >0.04.
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 21
TRANSBIOTEC
SOBR Display Conditions
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 22
LED Indicators Conditions• Green: Power On• Yellow: Blinks when testing
• Green: Pass• Red: Fail
• Red: Return to TBT• Blue: Blinks when test has failed or roll-started
without testing
Splash Screen TBT Version
Conditioning Wait 60
Testing Test 6
Pass Pass .0X
Fail Fail .0X
TRANSBIOTEC
Portable Handheld Device• Single-Touch Handheld device to test human alcohol levels
• Light weight, high-resolution display, and long battery life.
• Ease of Use – Single Touch
• Quality Design and build
• Display and battery life
• Camera (PLUS Model)
• Data Storage (PLUS Model)
• Software (PLUS Model)
• Wi-Fi (PLUS Model)
• USB port
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 23
TRANSBIOTEC
MARKETING
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 24
TRANSBIOTEC
Marketing Strategy• SOBR Product Line Employs Single-Touch Non-Invasive Technology:
Portable Handheld Device Interlock Ignition Device for Vehicles
• Marketing Objectives:
o Create brand awareness by marketing our products, positioning, and promoting Transbiotec corporate image in positive ways
o Maintain brand consistency to dominate in the global marketo Continuing focus on market segmentation and brand positioning
Brand Statements: o ”Best Single-Touch Blood Alcohol Sensor Device in the world”
Develop model upgrades in 2016.
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 25
TRANSBIOTEC
Global Markets
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 26
SSOBR
EUROPE• ITALY • SWEDEN• GERMANY
• LICENSING • SUB-ASSEMBLY PLANT• MASTER DISTRIBUTION• MAINTENANCE /
CALIBRATION / CERTIFICATION
Our mission: To become a globally focused corporation and to use the most advanced technology to convey our commitment to excellence and performance.
Our Values:Safety is paramount intention in the creation of SOBR.Work responsibly,lead by example,deliver quality and aim to exceed customers expectation.
• TRUCKING• LAW ENFORCEMENT• MILITARY• AFTER MARKET
DISTRIBUTION• INVESTORS• MAINTENANCE /
CALIBRATION / CERTIFICATION
ASIA• TURKEY• CHINA• AZERBAJAN• S KOREA• DUBAI• INDIA
USA• Strategic Partnership
CANADA• Strategic Partnership
TRANSBIOTEC
Marketing Essentials Channel Margin Unit Profit Margin Marketing Sales Force Advertising Distribution Pricing / Price Promotion Contingency
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 27
TRANSBIOTEC
Marketing and Public Relations
• Brand management and messaging
• Manage advertising opportunities
• Organize the availability of company members for media/PR events as necessary
• Oversee content, production, and distribution of all marketing and publicity materials (posters, program, flyers, mail outs, brochures etc) with director, designer, and project manager
• Manage press information
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 28
TRANSBIOTEC
SOBR Timeline
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 29
IID Purchase Orders Received
Sept 2015
Handheld Purchase
Orders FulfilledJune 2016
IID & Handheld PLUS 2nd Models
Purchase Orders2017
Marketing Development Measureables
TRANSBIOTEC
Potential Customers (US)
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 30
• Bellevue Washington Police Department
• Speedy Glass
• Santa Clara Police Department
• University of Washington
• Safelite Autoglass
• Zip Car
• PacWest Computer
• U. S. Navy
TRANSBIOTEC
Our Financial Strategy• Improve financial returns through a relentless focus on efficiency,
product quality, expense control across all business activities
• Deliver sustainable growth by embedding a corporate culture of excellence and performance which encompasses:
a. Customer’s value
b. Human capital management
c. Financial performance
d. Responsible behavior
TRANSBIOTEC PRIVATE / PROPRIETARY05/03/2023 31
TRANSBIOTEC
Pricing Strategy
• TRANSBIOTEC’s goal is to price its SOBR product line to cover G&A expenses, cost of goods sold, and to generate 150 percent profit margin. TBT will apply cutting edge technology to develop and market SOBR devices for professional and commercial use. TBT pricing will account for warranty claims and product liability insurance costs.
• TRANSBIOTEC will obtain Letters of Intents (LOI) from the North American and global markets . We have already established interest in the United States, Canada, India, Turkey and China. These customers are receptive to the selling price point.
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 32
TRANSBIOTEC
Executive Objectives• Increase sector-specific technology expertise
• Implement efficiency and cost effective programs
• Invest in human capital as a direct employer
• Improve our safety and sustainability performance
• Sustain our worldwide market position
• Expand in higher-growth domestic and international markets.
TRANSBIOTEC PRIVATE / PROPRIETARY05/03/2023 33
TRANSBIOTEC
• Ensure client and vendor file integrity (documents, analytical information where required, communication notations, etc.).
• Maintain general oversight and insure accuracy of records including A/R, A/P, Inventory, etc.
• Assist in development of forms and tools to increase company efficiency and risk management control.
• Provide leadership and vision to the organization by assisting the Board of Directors and staff with the development of long range and annual plans and with the evaluation and reporting of progress on plans.
• Oversee preparation of an Annual Report summarizing progress on short and long range plans.
• Research and write discussion papers, analyze documents and proposals as needed to assist the organization in determining and meeting its long and short term goals.
TRANSBIOTEC PRIVATE / PROPRIETARY05/03/2023 34
Administrative Management
TRANSBIOTEC
Financial Management• CFO to oversee investments and cash strategies
• Controller shall oversee preparation of annual budget, regular variance statements, and annual audit
• Provide vision regarding overall financial health of the company
• Provide vision and leadership in long range fiscal planning to ensure the continuity and solvency of the company
• Provide recommendations regarding effective utilization of long and short term debt, including refinancing and purchasing/sales
• Oversee fundraising efforts
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 35
TRANSBIOTEC
Expense Budget
TRANSBIOTEC PRIVATE / PROPRIETARY05/03/2023 36
• Implement systems to track expenses month by month and follow up on plan-vs.-actual expense analysis
• Programs
• Promotion
• Expense budget – Operation, Marketing Research and Development
TRANSBIOTEC
Our Manufacturing Teammates• ISO 9000 (9001:2008) Certification• IPC 610 CLASS III • IPC J-001 Certified Instructors• Turnkey material procurement assembly• Management Control over the entire project efficiently• High Quality electronics• On-Time Delivery• Maintain good quality with lower assembly cost • Meet and Exceed CUSTOMER EXPECTATION• 21 Years Experience• VIDEO : http://youtu.be/cUfkLE019Ds
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 37
TRANSBIOTEC
DIRECTORS & EXECUTIVE OFFICERS
• Charles Bennington has been our President and its Principal Executive, Financial and Accounting Officer since December 2006 and its Secretary since July 2013. Between May 2005 and December 2006 Mr. Bennington was TBT's Chief Operating Officer. Mr. Bennington has been a director of TBT since April 2005. Mr. Bennington holds a Degree in Finance and Banking from the University of Miami, Ohio. Mr. Bennington’s over 35 years of experience of positions held in senior executive management and/or as a member of the Board of Directors, combined with the fact he was TBT’s President at the time we acquired TBT and had experience with managing TBT’s development of the SOBR™ device led us to believe Mr. Bennington is an ideal director for our company considering where we are in our development, as well as our dependence on successfully implementing a strategy to further develop the SOBR™ device and attempt to sell it in various marketplaces.
• Ronald Williams has been our Chief Technology Officer since October 28, 2005. Mr. Williams has been a director of TBT since June 3, 2010. Since 1993, Mr. Williams has owned and operated a mixed fruit tree orchard in Fallbrook, California. Since 1972, Mr. Williams has worked as an aerospace engineer and since 2005 Mr. Williams has been employed by the Aerospace Corporation in El Segundo, California. Mr. Williams holds a Bachelor of Science Degree in physics from the University of California at Los Angeles and has performed graduate studies in mechanical and material engineering at Cal State Northridge. Mr. Williams’ experience of over 35 years of engineering experience, combined with the fact he was TBT’s Chief Technology Officer at the time we acquired TBT and had assisted with designing and developing the SOBR™ device led us to believe Mr. Williams is an ideal director for our company considering where we are in developing the SOBR™ device.
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 38
TRANSBIOTEC
DIRECTORS & EXECUTIVE OFFICERS continue
• Devadatt Mishal has been a director since June 3, 2010. Dr. Mishal has been practicing as an Obstetrician and Gynecologist since March 1982 in Downey, California. Dr. Mishal received his medical degree from Lokmanya Tilak. Mr. Mishal’s experience of over 30 years of experience managing his own business, combined with the fact he was one of TBT’s Directors at the time we acquired TBT and had experience with TBT’s development of the SOBR™ device led us to believe Mr. Mishal is an ideal director for our company.
• Daljit Khangura has been a director since November 2013. Mr. Khangura has been Sr. Finance Logistics Operations for AT&T, Inc. since June 2010. In this position, Mr. Khangura has managed inventory to approve, write, track and transfer jobs totaling hundreds of millions dollars managing over 900 field project orders, for field engineers and technician and third party vendors, as well as handling a multitude of other functions involving inventory, supply orders, and implementing various software and hardware rollouts. Prior to this position, Mr. Khangura was the Manager Procurement/Transportation for Clorox, Inc. from July 2009 to December 2010. In this position, Mr. Khangura prepared annual department operating budgets, managed expenses based on department budget, and approved budget spending targets, as well as spearheaded a strategic optimization project team consisting of 50 members with multiple functions. Mr. Khangura received a Bachelor of Science in Electrical/Mechanical and Business Management, as a double major, from West Bromwich College, England, UK University of the London, England, United Kingdom. Mr. Khangura’s extensive managerial experience in managing inventory and project orders led us to believe Mr. Khangura is an ideal director for our company.
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 39
TRANSBIOTEC
Summary• SOBR revolutionizes alcohol testing with state of the art Non-
Invasive technology.
With drunk driving being a global problem, the SOBR device will serve as a crucial safety check to save lives and reduce injuries.
SOBR is accurate and assures “Safety for the General Public”.
05/03/2023 TRANSBIOTEC PRIVATE / PROPRIETARY 40